Lupin receives EIR from U.S. FDA for Aurangabad facility
The Establishment Inspection Report follows a product-specific Pre-Approval Inspection conducted by the U.S. FDA at Lupin’s…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
U.S. FDA
Lupin receives approval from US FDA for Prucalopride Tablets
The approved tablets are bioequivalent to Takeda’s Motegrity and will be manufactured at Lupin’s Goa facility
Lupin’s Somerset facility clears U.S. FDA Pre-Approval Inspection for Edaravone Oral Suspension
Lupin announces completion of U.S. FDA Pre-Approval Inspection at its Somerset, New Jersey facility with zero 483 observations
Lupin launches Doxycycline for Injection USP in the United States
Generic equivalent of Vibramycin for Injection, the drug is indicated to reduce the development of drug-resistant bacteria and…